Effectiveness of 3 ways method in intra-arterial infusion chemotherapy for advanced or recurrent cervical cancer with or without radiotherapy

Y. Kaneyasu, M. Kita, Kuniaki Katsui, M. Kono, N. Kojima, K. Himei, M. Isobe, K. Karasawa, J. Toda, E. Yamanouchi, T. Okawa

Research output: Contribution to journalArticle

Abstract

We analyzed 58 cases of advanced or recurrent cervical cancer treated with intra-arterial infusion chemotherapy (IAIC) with or without radiotherapy. Two separate IAIC regimens were administered since 1985: group I consisted of 5-FU + MMC +/- ADR (30 patients) and group II consisted of CDDP + MMC +/- 5-FU (28 patients). The tip of a catheter was placed in the bifurcation of the abdominal aorta (1 way method: 45 patients regimen II: 15) between 1977-1984. We have used selective catheterization (2 ways method: 9) since 1995 in order to get good drug distribution. However we experienced grade 4 toxic effect of cutaneous and pain with this method, so we have used a 3 ways method (4 patients) since 1998. The two-year survival rete was 60% with the 1 way method, and 67% with the 2 ways method and regimen II. Severe adverse effects (grade 3 + 4) were found in 53, 56, 0%, respectively, by each of the three methods (1, 2, 3 ways) hematologically, 13, 22, 0% in gastrointestinally, 0, 44, 0% in cutaneously and 0, 56, 0% in pain or neurotoxicity. These data suggest that IAIC by the 3 ways method is a useful treatment for advanced or recurrent cervical cancer. However, one should check the blood flow distribution periodically, and control concentration of drugs.

Original languageEnglish
Pages (from-to)1860-1863
Number of pages4
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume26
Issue number12
Publication statusPublished - Oct 1999
Externally publishedYes

Fingerprint

Intra Arterial Infusions
Uterine Cervical Neoplasms
Radiotherapy
Drug Therapy
Fluorouracil
Pain
Poisons
Drug and Narcotic Control
Abdominal Aorta
Catheterization
Catheters
Skin
Survival

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology

Cite this

Effectiveness of 3 ways method in intra-arterial infusion chemotherapy for advanced or recurrent cervical cancer with or without radiotherapy. / Kaneyasu, Y.; Kita, M.; Katsui, Kuniaki; Kono, M.; Kojima, N.; Himei, K.; Isobe, M.; Karasawa, K.; Toda, J.; Yamanouchi, E.; Okawa, T.

In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 26, No. 12, 10.1999, p. 1860-1863.

Research output: Contribution to journalArticle

Kaneyasu, Y, Kita, M, Katsui, K, Kono, M, Kojima, N, Himei, K, Isobe, M, Karasawa, K, Toda, J, Yamanouchi, E & Okawa, T 1999, 'Effectiveness of 3 ways method in intra-arterial infusion chemotherapy for advanced or recurrent cervical cancer with or without radiotherapy', Gan to kagaku ryoho. Cancer & chemotherapy, vol. 26, no. 12, pp. 1860-1863.
Kaneyasu, Y. ; Kita, M. ; Katsui, Kuniaki ; Kono, M. ; Kojima, N. ; Himei, K. ; Isobe, M. ; Karasawa, K. ; Toda, J. ; Yamanouchi, E. ; Okawa, T. / Effectiveness of 3 ways method in intra-arterial infusion chemotherapy for advanced or recurrent cervical cancer with or without radiotherapy. In: Gan to kagaku ryoho. Cancer & chemotherapy. 1999 ; Vol. 26, No. 12. pp. 1860-1863.
@article{ece26c664f4d44318fdc2cae1360e47c,
title = "Effectiveness of 3 ways method in intra-arterial infusion chemotherapy for advanced or recurrent cervical cancer with or without radiotherapy",
abstract = "We analyzed 58 cases of advanced or recurrent cervical cancer treated with intra-arterial infusion chemotherapy (IAIC) with or without radiotherapy. Two separate IAIC regimens were administered since 1985: group I consisted of 5-FU + MMC +/- ADR (30 patients) and group II consisted of CDDP + MMC +/- 5-FU (28 patients). The tip of a catheter was placed in the bifurcation of the abdominal aorta (1 way method: 45 patients regimen II: 15) between 1977-1984. We have used selective catheterization (2 ways method: 9) since 1995 in order to get good drug distribution. However we experienced grade 4 toxic effect of cutaneous and pain with this method, so we have used a 3 ways method (4 patients) since 1998. The two-year survival rete was 60{\%} with the 1 way method, and 67{\%} with the 2 ways method and regimen II. Severe adverse effects (grade 3 + 4) were found in 53, 56, 0{\%}, respectively, by each of the three methods (1, 2, 3 ways) hematologically, 13, 22, 0{\%} in gastrointestinally, 0, 44, 0{\%} in cutaneously and 0, 56, 0{\%} in pain or neurotoxicity. These data suggest that IAIC by the 3 ways method is a useful treatment for advanced or recurrent cervical cancer. However, one should check the blood flow distribution periodically, and control concentration of drugs.",
author = "Y. Kaneyasu and M. Kita and Kuniaki Katsui and M. Kono and N. Kojima and K. Himei and M. Isobe and K. Karasawa and J. Toda and E. Yamanouchi and T. Okawa",
year = "1999",
month = "10",
language = "English",
volume = "26",
pages = "1860--1863",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "12",

}

TY - JOUR

T1 - Effectiveness of 3 ways method in intra-arterial infusion chemotherapy for advanced or recurrent cervical cancer with or without radiotherapy

AU - Kaneyasu, Y.

AU - Kita, M.

AU - Katsui, Kuniaki

AU - Kono, M.

AU - Kojima, N.

AU - Himei, K.

AU - Isobe, M.

AU - Karasawa, K.

AU - Toda, J.

AU - Yamanouchi, E.

AU - Okawa, T.

PY - 1999/10

Y1 - 1999/10

N2 - We analyzed 58 cases of advanced or recurrent cervical cancer treated with intra-arterial infusion chemotherapy (IAIC) with or without radiotherapy. Two separate IAIC regimens were administered since 1985: group I consisted of 5-FU + MMC +/- ADR (30 patients) and group II consisted of CDDP + MMC +/- 5-FU (28 patients). The tip of a catheter was placed in the bifurcation of the abdominal aorta (1 way method: 45 patients regimen II: 15) between 1977-1984. We have used selective catheterization (2 ways method: 9) since 1995 in order to get good drug distribution. However we experienced grade 4 toxic effect of cutaneous and pain with this method, so we have used a 3 ways method (4 patients) since 1998. The two-year survival rete was 60% with the 1 way method, and 67% with the 2 ways method and regimen II. Severe adverse effects (grade 3 + 4) were found in 53, 56, 0%, respectively, by each of the three methods (1, 2, 3 ways) hematologically, 13, 22, 0% in gastrointestinally, 0, 44, 0% in cutaneously and 0, 56, 0% in pain or neurotoxicity. These data suggest that IAIC by the 3 ways method is a useful treatment for advanced or recurrent cervical cancer. However, one should check the blood flow distribution periodically, and control concentration of drugs.

AB - We analyzed 58 cases of advanced or recurrent cervical cancer treated with intra-arterial infusion chemotherapy (IAIC) with or without radiotherapy. Two separate IAIC regimens were administered since 1985: group I consisted of 5-FU + MMC +/- ADR (30 patients) and group II consisted of CDDP + MMC +/- 5-FU (28 patients). The tip of a catheter was placed in the bifurcation of the abdominal aorta (1 way method: 45 patients regimen II: 15) between 1977-1984. We have used selective catheterization (2 ways method: 9) since 1995 in order to get good drug distribution. However we experienced grade 4 toxic effect of cutaneous and pain with this method, so we have used a 3 ways method (4 patients) since 1998. The two-year survival rete was 60% with the 1 way method, and 67% with the 2 ways method and regimen II. Severe adverse effects (grade 3 + 4) were found in 53, 56, 0%, respectively, by each of the three methods (1, 2, 3 ways) hematologically, 13, 22, 0% in gastrointestinally, 0, 44, 0% in cutaneously and 0, 56, 0% in pain or neurotoxicity. These data suggest that IAIC by the 3 ways method is a useful treatment for advanced or recurrent cervical cancer. However, one should check the blood flow distribution periodically, and control concentration of drugs.

UR - http://www.scopus.com/inward/record.url?scp=0033209020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033209020&partnerID=8YFLogxK

M3 - Article

C2 - 10560412

AN - SCOPUS:0033209020

VL - 26

SP - 1860

EP - 1863

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 12

ER -